Copyright
©The Author(s) 2025.
World J Psychiatry. Jun 19, 2025; 15(6): 103661
Published online Jun 19, 2025. doi: 10.5498/wjp.v15.i6.103661
Published online Jun 19, 2025. doi: 10.5498/wjp.v15.i6.103661
Table 1 Comparison of general information among three groups, mean ± SD
Characteristic | Control group (n = 55) | na-MCI group (n = 50) | a-MCI group (n = 52) | F value | P value |
Age (years) | 70.24 ± 3.44 | 71.18 ± 4.29 | 71.33 ± 4.82 | 1.063 | 0.348 |
Gender | 0.062 | 0.969 | |||
Male | 32 | 30 | 30 | ||
Female | 23 | 20 | 22 | ||
Body mass index (kg/m2) | 23.22 ± 2.10 | 23.40 ± 1.23 | 22.83 ± 1.24 | 1.685 | 0.189 |
Marital status | 1.109 | 0.575 | |||
Married or remarried | 37 | 29 | 31 | ||
Unmarried or divorced | 18 | 21 | 21 | ||
Education level | 12.484 | 0.014 | |||
Illiteracy | 7 | 14 | 20 | ||
Primary school | 19 | 21 | 16 | ||
Secondary school and above | 29 | 15 | 16 | ||
Occupation | 3.414 | 0.491 | |||
Unemployed | 11 | 15 | 18 | ||
Farmer | 25 | 20 | 17 | ||
Retired | 19 | 15 | 17 | ||
Living conditions | 3.228 | 0.199 | |||
Solitary | 17 | 24 | 21 | ||
Non-solitary | 38 | 26 | 31 | ||
Regular exercise | 9.040 | 0.011 | |||
With | 39 | 24 | 23 | ||
Without | 16 | 26 | 29 | ||
History of smoking | 28 | 35 | 33 | 4.193 | 0.123 |
History of drinking | 28 | 33 | 35 | 3.166 | 0.205 |
Hypertension | 31 | 32 | 30 | 0.709 | 0.702 |
Diabetes mellitus | 24 | 23 | 26 | 0.442 | 0.802 |
Hyperlipidemia | 27 | 22 | 25 | 0.300 | 0.861 |
APOE carrier | 12 | 15 | 0.308 | 0.579 |
Table 2 Comparison of various scale scores among three groups, mean ± SD
Control group (n = 55) | na-MCI group (n = 50) | a-MCI group (n = 52) | F value | P value | |
MoCA | 28.05 ± 0.85 | 21.86 ± 2.05a,1 | 21.23 ± 2.13a,1 | 247.0 | < 0.0001 |
AVLT-H-N5 | 6.16 ± 1.44 | 2.24 ± 0.69a,1 | 2.31 ± 0.58a,1 | 275.8 | < 0.0001 |
HAMA | 3.31 ± 2.10 | 5.16 ± 1.02a,1 | 7.06 ± 1.00a,1,2 | 85.25 | < 0.0001 |
HAMD | 1.95 ± 0.23 | 6.00 ± 0.64a,1 | 7.15 ± 0.61a,1,2 | 1488 | < 0.0001 |
ADL | 23.09 ± 1.17 | 26.24 ± 1.55a,1 | 28.58 ± 1.21a,1,2 | 234.9 | < 0.0001 |
Table 3 Comparison of cerebral blood flow among three groups, mean ± SD
CBF/(mL/100 g/minute) | Right | Left | ||||||||
Control group | na-MCI group | a-MCI group | F value | P value | Control group | na-MCI group | a-MCI group | F value | P value | |
Frontal lobe | 69.40 ± 3.51 | 70.72 ± 2.15a,1 | 53.37 ± 2.58a,1,2 | 606.4 | < 0.0001 | 63.34 ± 3.25 | 59.60 ± 2.27a,1 | 48.92 ± 2.60a,1,2 | 390.5 | < 0.0001 |
Temporal lobe | 53.31 ± 1.85 | 43.40 ± 1.37a,1 | 47.64 ± 1.42a,1,2 | 528.1 | < 0.0001 | 55.66 ± 2.02 | 51.67 ± 1.62a,1 | 48.89 ± 1.39a,1,2 | 213.7 | < 0.0001 |
Hippocampal head | 58.83 ± 2.63 | 51.38 ± 1.65a,1 | 48.71 ± 1.94a,1,2 | 325.7 | < 0.0001 | 53.77 ± 2.51 | 49.06 ± 2.20a,1 | 49.66 ± 2.42a,1 | 61.72 | < 0.0001 |
Hippocampus | 51.32 ± 2.15 | 50.16 ± 1.40a,1 | 45.87 ± 2.09a,1,2 | 117.8 | < 0.0001 | 49.78 ± 1.94 | 46.78 ± 1.61a,1 | 45.10 ± 1.98a,1,2 | 87.63 | < 0.0001 |
Cuneus | 55.20 ± 2.68 | 43.33 ± 1.55a,1 | 43.24 ± 1.64a,1 | 607.8 | < 0.0001 | 52.23 ± 2.41 | 41.69 ± 1.09a,1 | 46.90 ± 1.54a,1,2 | 455.1 | < 0.0001 |
Precuneus | 52.56 ± 2.36 | 49.67 ± 1.20a,1 | 44.74 ± 1.58a,1,2 | 256.8 | < 0.0001 | 55.17 ± 2.26 | 45.37 ± 1.34a,1 | 43.22 ± 1.50a,1,2 | 701.6 | < 0.0001 |
Parietal lobe | 49.91 ± 2.23 | 48.37 ± 1.66a,1 | 45.13 ± 1.37a,1,2 | 97.41 | < 0.0001 | 48.24 ± 1.34 | 45.61 ± 1.19a,1 | 42.53 ± 0.98a,1,2 | 311.9 | < 0.0001 |
Basal ganglia | 70.93 ± 2.38 | 67.66 ± 1.75a,1 | 60.67 ± 1.49a,1,2 | 394.2 | < 0.0001 | 70.53 ± 2.25 | 67.42 ± 2.24a,1 | 64.63 ± 1.74a,1,2 | 106.6 | < 0.0001 |
Occipital lobe | 47.98 ± 2.28 | 48.21 ± 1.67 | 45.46 ± 1.49a,1,2 | 35.10 | < 0.0001 | 48.20 ± 1.62 | 47.61 ± 1.69 | 45.25 ± 1.23a,1,2 | 55.12 | < 0.0001 |
Table 4 Comparison of blood-brain barrier permeability among three groups, mean ± SD
Ktrans | Right | Left | ||||||||
Control group | na-MCI group | a-MCI | F value | P value | Control group | na-MCI group | a-MCI | F value | P value | |
Frontal lobe | 0.01 ± 0.01 | 0.13 ± 0.01a,1 | 0.03 ± 0.01a,1,2 | 2126 | < 0.0001 | 0.09 ± 0.01 | 0.19 ± 0.02a,1 | 0.02 ± 0.01a,1,2 | 1901 | < 0.0001 |
Temporal lobe | 0.05 ± 0.02 | 0.10 ± 0.02a,1 | 0.08 ± 0.02a,1,2 | 83.51 | < 0.0001 | 0.02 ± 0.01 | 0.11 ± 0.01a,1 | 0.02 ± 0.01a,2 | 1380 | 0.867 |
Hippocampal area | 0.02 ± 0.01 | 0.06 ± 0.01a,1 | 0.13 ± 0.03a,1,2 | 451.6 | < 0.0001 | 0.01 ± 0.01 | 0.03 ± 0.01a,1 | 0.09 ± 0.03a,1,2 | 251.0 | < 0.0001 |
Table 5 Comparison of the levels of biochemical indexes of the subjects, mean ± SD
Biochemical indexes | Control group (n = 55) | na-MCI group (n = 50) | a-MCI group (n = 52) | χ2/t value | P value |
Hcy (μmol/L) | 10.47 ± 2.91 | 12.62 ± 2.15a,1 | 13.40 ± 2.21a,1,2 | 20.42 | < 0.0001 |
Aβ42 (pg/mL) | 129.38 ± 15.49 | 107.20 ± 7.66a,1 | 89.87 ± 12.17a,1,2 | 138.4 | < 0.0001 |
Aβ40 (pg/mL) | 151.65 ± 40.52 | 147.34 ± 21.94 | 147.63 ± 34.30 | 0.278 | 0.758 |
p-tau181 (pg/mL) | 14.22 ± 1.99 | 31.77 ± 4.69a,1 | 40.66 ± 4.11a,1,2 | 695.1 | < 0.0001 |
ICAM-1 (g/mL) | 117.29 ± 16.43 | 215.99 ± 25.44a,1 | 286.60 ± 33.44a,1,2 | 577.9 | < 0.0001 |
VCAM-1 (mg/L) | 1.79 ± 0.26 | 2.23 ± 0.31a,1 | 2.50 ± 0.51a,1,2 | 49.07 | < 0.0001 |
PAI-1 (ng/L) | 314.59 ± 32.81 | 366.83 ± 36.77a,1 | 397.75 ± 45.68a,1,2 | 63.26 | < 0.0001 |
NFL (pg/mL) | 18.55 ± 4.90 | 39.22 ± 6.77a,1 | 46.70 ± 6.44a,1,2 | 311.1 | < 0.0001 |
GFAP (ng/mL) | 4.00 ± 0.23 | 8.68 ± 1.09a,1 | 9.48 ± 3.19a,1 | 125.0 | < 0.0001 |
- Citation: Sun L, Xu MR, Zhou CY, Cao SD, Zhang XL, Guan SQ, Sang WX, Li XL. Diagnostic dynamic contrast-enhanced magnetic resonance imaging blood-brain barrier assessment combined with plasma biomarkers for mild cognitive impairment. World J Psychiatry 2025; 15(6): 103661
- URL: https://www.wjgnet.com/2220-3206/full/v15/i6/103661.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i6.103661